Header Logo

Connection

CHANDRA BARTHOLOMEUSZ to G1 Phase

Back to Details
This is a "connection" page, showing publications CHANDRA BARTHOLOMEUSZ has written about G1 Phase.
CHANDRA BARTHOLOMEUSZ
Connection Strength
0.109
G1 Phase
  1. MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther. 2012 Feb; 11(2):360-9.
    View in: PubMed
    Score: 0.092
  2. Sensitivity of breast cancer cells to erlotinib depends on cyclin-dependent kinase 2 activity. Mol Cancer Ther. 2007 Aug; 6(8):2168-77.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.